VDAC1 and glioblastoma: In sub-cutaneous and intracranial-orthotopic GBM xenograft mouse models, VDAC1-based peptides inhibited tumor development by inducing massive apoptotic cell death involving enhanced expression of pro-apoptotic proteins, eliminating cancer stem cells (CSCs) and reversing the metabolic reprograming of the cancer cells.